Angel investor · Philadelphia, United States
Recorded investments.
A clearer sense of fit.
Find where your company fits, how rounds are assembled, and what happened after the first investment.
of dated first investments
were at Angel, Pre-Seed or Seed
One dot = one company at first recorded investment.
Written insights from the recorded portfolio, with the evidence linked below.
Josh Kopelman has dated investments in 5 companies. 4 first entries were at Angel, Pre-Seed or Seed (80.0%). An early-stage founder can use the sector and stage filters to find comparable companies before approaching the investor.
Explore the evidence ↗0 first company relationships appear in the latest 24 months, compared with 1 in the preceding window. The latest recorded investment is 2022-12-08. This describes observed activity through 2026-05-22; it does not establish current availability.
Explore the evidence ↗4 of 5 companies with a full 24-month observation window raised another equity round. This investor backed 0 of those companies again within that window. The difference is a reason to research the wider syndicate, rather than assume the same investor will fund the next round.
Explore the evidence ↗EdTech is the largest displayed sector by company count, appearing in 2 portfolio companies; sector tags overlap. 3 first entries carry a recorded lead flag and the median first-round syndicate includes 5 other named backers. Shared rounds are evidence of co-investment, not evidence of an introduction route.
Explore the evidence ↗Start with observed behavior.
Every rate has a defined denominator.
25th–75th percentile across 5 disclosed first rounds. Total round size; the investor’s own cheque is undisclosed.
Size your round ↗22 May 2024–22 May 2026, versus 1 in the preceding 24 months.
See the rhythm ↗4 of 5 companies with a full observation window. The next round can include any investor.
Follow the path ↗0 of the same 5 companies. Build a financing plan around the wider investor market.
Explore co-investors ↗Choose your sector and stage to find
companies he first backed in that space.
A match means a recorded investment in this category. It does not establish current interest or availability.
All sectors · All entry stages. Round amounts are total financing, in USD.
Developer of combination therapeutics for cancer treatment
$7.0M total first roundDeveloper of an AI-powered workspace for team collaboration and productivity
$18M total first roundA how-to guide curated by the community
$300K total first round| Sector | Angel | Seed | Series B | All stages |
|---|---|---|---|---|
| EdTech | 2 | |||
| Antibody Based Immunotherapy | 1 | |||
| Biopharmaceuticals | 1 | |||
| Cancer Immunotherapy | 1 | |||
| Immunotherapy | 1 | |||
| Life Sciences | 1 | |||
| Oncology | 1 |
Use stage-specific financing ranges
to frame the size of your syndicate.
Logarithmic scale. A dot marks the median; the band spans the 25th–75th percentiles. These are entire rounds, not individual cheques.
A subsequent round and repeat backing
answer different fundraising questions.
Includes first investments on or before 22 May 2024. 0 newer companies and 1 undated histories are excluded. Follow-up stops at the dataset’s latest round on 22 May 2026. These observations do not measure returns or predict a company’s outcome.
| First stage | Eligible companies | Next round ≤24 mo | Same investor again ≤24 mo |
|---|---|---|---|
| Angel | 1 | 1 / 1 | 0 / 1 |
| Seed | 3 | 2 / 3 | 0 / 3 |
| Series B | 1 | 1 / 1 | 0 / 1 |
Separate first investments from later
rounds in companies already backed.
*2026 is partial, through 22 May. Bar height counts first investments + repeat rounds; earlier years are complete calendar periods in this dataset.
Frequent shared rounds suggest a place
to investigate sector and stage alignment.
1 shared rounds · 1 companies
Latest shared round Dec 20221 shared rounds · 1 companies
Latest shared round Jan 20121 shared rounds · 1 companies
Latest shared round Aug 20141 shared rounds · 1 companies
Latest shared round Dec 20221 shared rounds · 1 companies
Latest shared round Dec 2022Shared rounds establish recorded co-investment. They do not establish a personal connection, introduction route, or current willingness to invest.
First investment comes first.
Amounts refer to that entry round.
| Company | First backed | Entry stage | Total entry round | Same investor again? |
|---|---|---|---|---|
EIGEN THERAPEUTICS ↗Redwood City | Dec 2022 | Seed | $7.0M | No later round recorded |
Notion ↗San Francisco | Jul 2019 | Angel | $18M | No later round recorded |
Squareknot ↗Philadelphia | Aug 2014 | Seed | $300K | No later round recorded |
Pando ↗San Francisco | Jan 2012 | Seed | $2.5M | No later round recorded |
Kno ↗Santa Clara | Dec 2009 | Series B | $7.5M | No later round recorded |
No companies match these filters. Try a broader sector or stage.
Kept in the 6-company portfolio; excluded from entry-timing calculations.
Search Philadelphia, United States investor companies in Radar. Filter the company directory to explore the businesses behind your market and investor research.
Explore companies in Radar ↗We build customized research dashboards for companies. Tell us which competitors, markets and questions matter to your team, and discuss a dashboard designed around your needs.
Discuss a custom dashboard ↗A customized service from Fliar. Contact us to discuss your requirements.Use Fliar Prism to research a company, market or topic, with reports and insights drawn from its research dataset.
Explore Fliar Prism ↗Start with the company or question you want to understand.